Current Concepts for the Evaluation and Management of Diabetic Foot Ulcers

Overview

Journal EFORT Open Rev

Specialty Orthopedics

Date 2018 Oct 12

PMID 30305936

Citations 26

Authors

Andreas F Mavrogenis

Panayiotis D Megaloikonomos

Thekla Antoniadou

Vasilios G Igoumenou

Georgios N Panagopoulos

Leonidas Dimopoulos

Konstantinos G Moulakakis

George S Sfyroeras

Andreas Lazaris

Affiliations

Soon will be listed here.

Abstract

The lifetime risk for diabetic patients to develop a diabetic foot ulcer (DFU) is 25%. In these patients, the risk of amputation is increased and the outcome deteriorates.More than 50% of non-traumatic lower-extremity amputations are related to DFU infections and 85% of all lower-extremity amputations in patients with diabetes are preceded by an ulcer; up to 70% of diabetic patients with a DFU-related amputation die within five years of their amputation.Optimal management of patients with DFUs must include clinical awareness, adequate blood glucose control, periodic foot inspection, custom therapeutic footwear, off-loading in high-risk patients, local wound care, diagnosis and control of osteomyelitis and ischaemia. Cite this article: 2018;3:513-525. DOI: 10.1302/2058-5241.3.180010.

Citing Articles

Gentiopicroside targeting AKT1 activates HIF-1α/VEGF axis promoting diabetic ulcer wound healing.

Wang X, Liu M, Wu Y, Sun J, Liu L, Pan Z Front Pharmacol. 2025; 16:1506499.

PMID: 40078292 PMC: 11897484. DOI: 10.3389/fphar.2025.1506499.

Delayed Immune Response Upon Injury in Diabetic Wounds Impedes Healing.

Dhanraj P, Boodhoo K, van de Vyver M Immun Inflamm Dis. 2025; 13(2):e70142.

PMID: 39891428 PMC: 11786017. DOI: 10.1002/iid3.70142.

Material Technologies for Improved Diabetic Foot Ulcer (DFU) Treatment: A Questionnaire Study of Healthcare Professionals' Needs.

Vargas Guerrero M, Vonken L, Peters E, Lucchesi J, Arts J Biomedicines. 2024; 12(11).

PMID: 39595050 PMC: 11592356. DOI: 10.3390/biomedicines12112483.

Amputation versus circular external fixation in the treatment of diabetic foot with osteomyelitis: a cost and quality-of-life analysis.

Lopez Capdevilla L, Santamaria Fumas A, Sales Perez J, Dominguez Sevilla A, Del Corral Cuervo J, Varela-Quintana C Ther Adv Endocrinol Metab. 2024; 15:20420188241271795.

PMID: 39483172 PMC: 11526285. DOI: 10.1177/20420188241271795.

Risk Prediction of Diabetic Foot Amputation Using Machine Learning and Explainable Artificial Intelligence.

Oei C, Chan Y, Zhang X, Leo K, Yong E, Chong R J Diabetes Sci Technol. 2024; :19322968241228606.

PMID: 38288696 PMC: 11571574. DOI: 10.1177/19322968241228606.

References

Kastenbauer T, Hornlein B, Sokol G, Irsigler K . Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia. 2003; 46(1):27-30. DOI: 10.1007/s00125-002-0998-z. View

Abbruzzese L, Iacopi E, Coppelli A, Bonino G, Goretti C, Piaggesi A . Safety and effectiveness of therapeutic magnetic resonance in the management of postsurgical lesion of the diabetic foot. Int J Low Extrem Wounds. 2015; 14(1):4-10. DOI: 10.1177/1534734614568374. View

Lipsky B, Hoey C . Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis. 2009; 49(10):1541-9. DOI: 10.1086/644732. View

McCallum J, Lane 3rd J . Angiosome-directed revascularization for critical limb ischemia. Semin Vasc Surg. 2015; 27(1):32-7. DOI: 10.1053/j.semvascsurg.2014.11.003. View

Peter-Riesch B . The Diabetic Foot: The Never-Ending Challenge. Endocr Dev. 2016; 31:108-34. DOI: 10.1159/000439409. View

Javed S, Petropoulos I, Tavakoli M, Malik R . Clinical and diagnostic features of small fiber damage in diabetic polyneuropathy. Handb Clin Neurol. 2014; 126:275-90. DOI: 10.1016/B978-0-444-53480-4.00019-9. View

Vardakas K, Horianopoulou M, Falagas M . Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials. Diabetes Res Clin Pract. 2008; 80(3):344-51. DOI: 10.1016/j.diabres.2008.01.009. View

Snyder R, Frykberg R, Rogers L, Applewhite A, Bell D, Bohn G . The management of diabetic foot ulcers through optimal off-loading: building consensus guidelines and practical recommendations to improve outcomes. J Am Podiatr Med Assoc. 2014; 104(6):555-67. DOI: 10.7547/8750-7315-104.6.555. View

Braun J, Trinidad-Hernandez M, Perry D, Armstrong D, Mills Sr J . Early quantitative evaluation of indocyanine green angiography in patients with critical limb ischemia. J Vasc Surg. 2013; 57(5):1213-8. DOI: 10.1016/j.jvs.2012.10.113. View

10.

Aragon-Sanchez J . Seminar review: A review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds. 2011; 10(1):33-65. DOI: 10.1177/1534734611400259. View

11.

Reed K, Pai M . Adjunctive granulocyte colony-stimulating factor therapy for diabetic foot infections. Ann Pharmacother. 2004; 38(12):2150-3. DOI: 10.1345/aph.1E185. View

12.

Tendera M, Aboyans V, Bartelink M, Baumgartner I, Clement D, Collet J . ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and.... Eur Heart J. 2011; 32(22):2851-906. DOI: 10.1093/eurheartj/ehr211. View

13.

Apelqvist J, Lepantalo M . The ulcerated leg: when to revascularize. Diabetes Metab Res Rev. 2012; 28 Suppl 1:30-5. DOI: 10.1002/dmrr.2259. View

14.

Hingorani A, LaMuraglia G, Henke P, Meissner M, Loretz L, Zinszer K . The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg. 2016; 63(2 Suppl):3S-21S. DOI: 10.1016/j.jvs.2015.10.003. View

15.

Cruciani M, Lipsky B, Mengoli C, de Lalla F . Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections?: A meta-analysis. Diabetes Care. 2005; 28(2):454-60. DOI: 10.2337/diacare.28.2.454. View

16.

Barrientos S, Brem H, Stojadinovic O, Tomic-Canic M . Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen. 2014; 22(5):569-78. PMC: 4812574. DOI: 10.1111/wrr.12205. View

17.

Craig A, Strauss M, Daniller A, Miller S . Foot sensation testing in the patient with diabetes: introduction of the quick & easy assessment tool. Wounds. 2015; 26(8):221-31. View

18.

Driver V, Blume P . Evaluation of wound care and health-care use costs in patients with diabetic foot ulcers treated with negative pressure wound therapy versus advanced moist wound therapy. J Am Podiatr Med Assoc. 2014; 104(2):147-53. DOI: 10.7547/0003-0538-104.2.147. View

19.

Bakker K, Apelqvist J, Schaper N . Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012; 28 Suppl 1:225-31. DOI: 10.1002/dmrr.2253. View

20.

Forsythe R, Hinchliffe R . Assessment of foot perfusion in patients with a diabetic foot ulcer. Diabetes Metab Res Rev. 2016; 32 Suppl 1:232-8. DOI: 10.1002/dmrr.2756. View